id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-1663-0033,FDA,FDA-2020-N-1663,National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers; Extension of Comment Period,Proposed Rule,Extension of Comment Period,2022-05-24T04:00:00Z,2022,5,2022-05-24T04:00:00Z,2022-09-07T03:59:59Z,2022-09-08T01:00:57Z,2022-11116,0,0,09000064850dbf26
FDA-2020-N-1663-0023,FDA,FDA-2020-N-1663,Request for Extension from Healthcare Distribution Alliance (HDA),Other,Request for Extension,2022-04-14T04:00:00Z,2022,4,2022-04-14T04:00:00Z,,2022-04-14T16:29:40Z,,0,0,090000648501a5f7
FDA-2020-N-1663-0008,FDA,FDA-2020-N-1663,Ref 4 - Effect of Section 585 Guidance RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:37:54Z,,0,0,090000648500f7e8
FDA-2020-N-1663-0007,FDA,FDA-2020-N-1663,Ref 3 - Latta RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:37:48Z,,0,0,090000648500f7ee
FDA-2020-N-1663-0014,FDA,FDA-2020-N-1663,Ref 10 - DOJ 5-2015 indictments RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:38:28Z,,0,0,090000648500cf8d
FDA-2020-N-1663-0006,FDA,FDA-2020-N-1663,Ref 2 - Matheson RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:37:43Z,,0,0,090000648500f79b
FDA-2020-N-1663-0015,FDA,FDA-2020-N-1663,Ref 11 - DOJ 5-2014 guilty pleas drug diversion RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:38:32Z,,0,0,090000648500f7f0
FDA-2020-N-1663-0019,FDA,FDA-2020-N-1663,Ref 15 - PIC-S RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:38:51Z,,0,0,090000648500f7f1
FDA-2020-N-1663-0016,FDA,FDA-2020-N-1663,Ref 12 - NABP Model state rules RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:38:37Z,,0,0,090000648500f7f4
FDA-2020-N-1663-0018,FDA,FDA-2020-N-1663,Ref 14 - WHO good distribution practices RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:38:46Z,,0,0,090000648500f7f5
FDA-2020-N-1663-0022,FDA,FDA-2020-N-1663,Ref 18 - Economic Analysis RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:39:07Z,,0,0,090000648500f057
FDA-2020-N-1663-0013,FDA,FDA-2020-N-1663,Ref 9 - NABP 7-2013 report RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:38:16Z,,0,0,090000648500f7ed
FDA-2020-N-1663-0020,FDA,FDA-2020-N-1663,Ref 16 - PDMA report to Congress RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:38:56Z,,0,0,090000648500f7f7
FDA-2020-N-1663-0009,FDA,FDA-2020-N-1663,Ref 5 - Ducca HDMA 585 guidance comment RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:37:58Z,,0,0,090000648500f7ec
FDA-2020-N-1663-0005,FDA,FDA-2020-N-1663,Ref 1 - Mikulski RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:37:37Z,,0,0,090000648500f052
FDA-2020-N-1663-0012,FDA,FDA-2020-N-1663,Ref 8 - FDLI WDD-3PL Presentation RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:38:12Z,,0,0,090000648500f7eb
FDA-2020-N-1663-0017,FDA,FDA-2020-N-1663,Ref 13 - HDA model 3PL standards RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:38:41Z,,0,0,090000648500f7f6
FDA-2020-N-1663-0010,FDA,FDA-2020-N-1663,Ref 6 - PDSA 585 guidance comment RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:38:03Z,,0,0,090000648500f7e9
FDA-2020-N-1663-0021,FDA,FDA-2020-N-1663,Ref 17 - NABP 5 rule RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:39:00Z,,0,0,090000648500f7ef
FDA-2020-N-1663-0011,FDA,FDA-2020-N-1663,Ref 7 - HIDA 585 guidance comment RE National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Supporting & Related Material,Background Material,2022-04-12T04:00:00Z,2022,4,,,2022-04-12T12:38:07Z,,0,0,090000648500f7ea
FDA-2020-N-1663-0001,FDA,FDA-2020-N-1663,National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2022-02-04T05:00:00Z,2022,2,2022-02-04T05:00:00Z,2022-09-07T03:59:59Z,2022-09-07T01:00:48Z,2022-01929,0,0,0900006484f549bd